REMEDY : BNSSG referral pathways & Joint Formulary


Home > Children & Young People > Dermatology >

Dermoid Cysts

Checked: 23-11-2022 by Rob Adams Next Review: 23-11-2023

Overview

A dermoid cyst is a developmental cyst resulting from inclusion of embryonic epithelium at sites of embryonic fusion. Unlike epidermoid cysts, dermoid cysts contain various adnexal structures (hair, sebaceous, eccrine or apocrine glands) and, rarely, other tissues such as bone, teeth and nerves (1).

Please see PCDS for further advice on recognition and management:

Dermoid cyst (pcds.org.uk)

Other features:

  • Often present at birth, nearly all present before the age of five years
  • Predominantly they occur on the head and neck area
  • Untreated, dermoid cysts persist and may later grow
  • They may have deep connections and so if lesions need to be excised the patient should be referred.
  • It is sometimes necessary to perform imaging prior to surgery to find out the extent of the lesion eg midline tumours of the face can have intra-cranial connections and those of the back intra-spinal connections

Referral

Suspected dermoid cysts in babies and children under the age of 5 should be referred to paediatric dermatology via eRS for a diagnostic opinion and excision if required. Referral is not subject to prior approval or EFR as these are not considered benign skin lesions.

Suspected dermoid cysts in older children and adults can be sent for USS and/or should be photographed and an opinion obtained from either:

Paediatric dermatology advice and guidance (patients aged under 16 yo)

Adult dermatology advice and guidance (patients aged 16 and over).

If a referral is recommended following imaging or A and G then this can be made via eRS without prior approval/EFR.

(1) Dermoid cyst (pcds.org.uk)

(2) Dermoid cysts | DermNet (dermnetnz.org)



Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.